BARD1 is a protein released in an aberrant form by cancer cells and that is used for the diagnostic of lung cancer. BARD1AG is developing a non-invasive test based on BARD1 antibodies and RNA splice-variants. The tests are composed of an ELISA-based test (“screening”) to detect anti-BARD1 antibodies in serum, followed by an analysis of BARD1 isoforms-specific RNA in circulating tumour cells (CTCs) (“final diagnosis”). Both tests are expected to be “CE-marked” by fall 2013. The tests will be asked for by your doctor, who will first puncture a small drop of blood and send it to BARD1AG for analysis. If positive, you will be asked for a second, and somewhat larger blood sampling for definitive diagnosis.

Korea Research Institute of Bioscience and Biotechnology (KRIBB) is a government research institute in Daejeon, South Korea. It is dedicated to biotechnology research across a broad span of expertise, from basic studies for the fundamental understanding of life phenomena to applied studies such as drug discovery, novel biomaterials, integrated biotechnology and bioinformation.

The Max Planck Society for the Advancement of Science (German: Max-Planck-Gesellschaft zur Förderung der Wissenschaften e. V.; abbreviated MPG) is a non-governmental and non-profit association of Research Institutes publicly funded by the federal and the state governments of Germany. Additionally, the Max Planck Society and its Institutes receive third party funding from public and private contributions and from the European Union. The world leading organization is named in honor of its former president, theoretical physicist Max Planck. The 86 Institutes and Research Facilities of the Max Planck Society (as of 2020) conduct basic research in the natural sciences, life sciences, social sciences, and the arts and humanities. They have a total staff of approximately 24,000 permanent employees, including 15,000 scientists, and around 5,000 non-tenured scientists and guests. As of December 31, 2018, the proportion of female employees was 44.4 percent. The Max Planck Society (with its 86 Max Planck Institutes) has a world-leading reputation as a science and technology research organization, with more than 33 Nobel Prizes awarded to its scientists, and is widely regarded as one of the foremost basic research organizations in the world.

Akzo Nobel NV is a holding company, which engages in the manufacture and sale of coating and paint products. engages in the production and marketing of paints and coatings. It operates through the following segments: Decorative Paintings, Performance Paintings, and Corporate and Others. The Decorative Paints segment manufactures and supplies a range of interior and exterior decoration and protection products for professional and do-it-yourself markets. The Performance Coatings segment produces automotive and aerospace; industrial; marine and protective; and powder coatings. The company was founded in 1792 and is headquartered in Amsterdam, Netherlands.

Shanghai Rongsheng Biotech Co., Ltd. principally engages in the research, development, production, and sale of vaccines and in vitro diagnostic reagents. Its products include vaccines, immunodiagnosis reagents, and biochemical diagnosis reagents. The company was founded by Shao Rong Zhu in 1988 and is headquartered in Shanghai, China.

Guangzhou Leide Bioscience Co., Ltd. (doing business as LDEBIO) is a Chinese company located in Guangzhou that develops vitro diagnostic technology. It was founded by Jian Rong Lou.

Sichuan Xieguang Biotechnology Co., Ltd., established on 2018-01-17, Business scope includes licensed projects:Class III medical device business;Production of Class III Medical Devices;Class III Medical Device Leasing;Production of Class II Medical Devices(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Health food production;Research and development of bio-based materials technology;Class II Medical Device Leasing;Sales of Class II Medical Devices;Sales of bio-based materials;Manufacturing of bio-based materials;Research and development of bio-based material polymerization technology;Biochemical product technology research and development;Sales of Class I Medical Devices;Production of Class I Medical Devices;Healthy food(prepackaged)Sales;Technology Import and Export;Import and export;Import and export agency;sales agent;Information Technology Consulting Services;Domestic trade agent;Chemical product sales(No licensed chemical products);Development of Human Gene Diagnosis and Therapy Technology;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;software development;Medical Research and Experimental Development;Special Equipment Repair;Manufacturing of special equipment(Manufacture of licensed professional equipment not included);Machinery sales;General machinery and equipment installation services;Sales of hygiene products and single-use medical products;General Equipment Repair;General equipment manufacturing(Does not include special equipment manufacturing);Engineering and Technology Research and Experimental Development;Chemical product production(No licensed chemical products)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Xi'an Best Biotechnology Co., Ltd., established on 2011-04-25, Business scope includes general business items:Development of biomedicine and technology products,Medical Information Technology Consulting;Biochip production,Import and export of goods and technology(Except for goods and technologies that are restricted and prohibited from import and export by the state);Molecular biology experiments and offshore technology outsourcing services;Class I medical device,Experimental equipment and consumables,Sales of reagents.(The above business scope excludes the special control and pre-licensing items stipulated by the state)

ProteomeTech, Inc. engages in the manufacture and sale of medical equipment. Its products include allergy screening kit and human immunoglobulin G rapid test. The company was founded on March 22, 2000 and is headquartered in Seoul, South Korea.

Green Cross continues to build on a long legacy of providing life-saving and life-sustaining specialty therapeutics. Their bioscience division began its business in 1971 as producing plasma-derived biotherapies for the first time in Korea. For more than 40 years, they have specialized in providing biotherapeutics to improve the quality of life for people with rare and serious diseases worldwide. Their vaccine business develops and produces paediatric and adult vaccine against a broad range of infectious diseases, from world’s 3rd hepatitis B vaccine to quadrivalent influenza vaccine. With their mission to improve health and well-being of people around the world, they have gone down a path that nobody wishes to explore. Their extensive research and development of innovative medicines that support treatment and prevention as well as cures for diseases in a wide range of therapeutic areas demonstrate their ongoing commitment to all people who rely on their products.

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Part of Formosa Chemicals & Fibre Corp., Linkou Chang Gung Memorial Hospital is a company headquartered in Taoyuan City, Taiwan, that operates medical and surgical hospital.

Jiangsu Drop Logic Biotechnology Co., Ltd., established on 2019-05-28, Business scope includes biotechnology,Technology development in the field of semiconductor technology,technology transfer,technical consulting,Technical Services;Medical device production(according to<Medical device production license>Approved scope of operation);Medical Device Sales(according to<Medical Device Business License>Approved scope of operation);Import and export business of goods and technology.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shandong Dongxing Huizhi Biotechnology Co., Ltd., established on 2011-08-16, Business scope includes industrial enzymes,Medical and animal husbandry diagnostic kits,Technology research and development and transfer of protein pharmaceutical raw materials.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Anhui Jianlang Medical Equipment Co., Ltd., established on 2018-04-20, The scope of business includes,Class II,Three types of medical device research and development,Production,Sales,Biotechnology,Technology development in the field of health industry,Technical Services,technical consulting,technology transfer,Intelligent software development,Research and development of intelligent control equipment.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)